Product Details

Verodia Capsules deliver Diacerein for the management of osteoarthritis. Specifically, each capsule contains 50mg of Diacerein IP. As a result, it offers a slow-acting, disease-modifying option for the long-term management of joint pain and cartilage degradation.

The capsules contain:

• Diacerein IP (50mg) – An anthraquinone derivative that inhibits interleukin-1 (IL-1) production and activity. Consequently, it reduces cartilage degradation and inflammation associated with osteoarthritis, offering a slower-onset but sustained therapeutic effect compared to conventional NSAIDs.

Physicians prescribe Verodia for the symptomatic management of osteoarthritis of the knee and hip, particularly as part of long-term treatment strategies aimed at slowing disease progression. In addition, its distinct mechanism of action makes it a useful adjunct or alternative to NSAID-based pain management. Because of this profile, Verodia suits rheumatology and orthopaedic practices managing chronic osteoarthritic joint conditions.

Key Features:

• Overall, this IP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the oral capsule format supports easy, convenient dosing
• Furthermore, each capsule delivers precise, validated dosage accuracy at 50mg
• Notably, rigorous quality testing backs every stage of manufacturing
• Beyond that, blister packaging protects capsule integrity against light and moisture
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and pharmacies